R. Michael Kenison's Insider Trades & SAST Disclosures
R. Michael Kenison's most recent trade in Proto Labs Inc was a trade of 6,943 Common Stock done . Disclosure was reported to the exchange on Feb. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern R. Michael Kenison.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Proto Labs Inc | Michael R. Kenison | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 6,943 | 28,982 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | Michael R. Kenison | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 6,231 | 6,231 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Michael R. Kenison | Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 1,894 | 24,315 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | Michael R. Kenison | Chief Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.03 per share. | 13 Feb 2025 | 1,696 | 22,039 (0%) | 0% | 45.0 | 76,371 | Common Stock |
| Proto Labs Inc | Michael R. Kenison | Chief Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.03 per share. | 13 Feb 2025 | 580 | 23,735 (0%) | 0% | 45.0 | 26,117 | Common Stock |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.81 per share. | 20 May 2024 | 336 | 22,351 (0%) | 0% | 31.8 | 10,688 | Common Stock |
| Proto Labs Inc | R. Michael Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 8,205 | 22,405 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | R. Michael Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 7,555 | 7,555 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.52 per share. | 13 Feb 2024 | 1,070 | 14,200 (0%) | 0% | 33.5 | 35,866 | Common Stock |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 8,127 | 14,724 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 7,712 | 7,712 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 4,064 | 4,064 | - | - | Performance Stock Units | |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,048 | 3,048 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.23 per share. | 13 Feb 2023 | 340 | 6,597 (0%) | 0% | 34.2 | 11,638 | Common Stock |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.68 per share. | 23 May 2022 | 771 | 6,675 (0%) | 0% | 45.7 | 35,219 | Common Stock |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 4,042 | 4,042 | - | - | Employee Stock Option (right to buy) | |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 3,788 | 7,221 (0%) | 0% | 0 | Common Stock | |
| Proto Labs Inc | Michael R. Kenison | VP and GM of the Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,894 | 1,894 | - | - | Performance Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges